Converging findings of animal and human studies provide compelling evidence that the amygdala is critically involved in enabling us to acquire and retain lasting memories of emotional experiences. This review focuses primarily on the findings of research investigating the role of the amygdala in modulating the consolidation of long-term memories. Considerable evidence from animal studies investigating the effects of posttraining systemic or intra-amygdala infusions of hormones and drugs, as well as selective lesions of specific amygdala nuclei, indicates that (a) the amygdala mediates the memory-modulating effects of adrenal stress hormones and several classes of neurotransmitters; (b) the effects are selectively mediated by the basolateral complex of the amygdala (BLA); (c) the influences involve interactions of several neuromodulatory systems within the BLA that converge in influencing noradrenergic and muscarinic cholinergic activation; (d) the BLA modulates memory consolidation via efferents to other brain regions, including the caudate nucleus, nucleus accumbens, and cortex; and (e) the BLA modulates the consolidation of memory of many different kinds of information. The findings of human brain imaging studies are consistent with those of animal studies in suggesting that activation of the amygdala influences the consolidation of long-term memory; the degree of activation of the amygdala by emotional arousal during encoding of emotionally arousing material (either pleasant or unpleasant) correlates highly with subsequent recall. The activation of neuromodulatory systems affecting the BLA and its projections to other brain regions involved in processing different kinds of information plays a key role in enabling emotionally significant experiences to be well remembered.
Roozendaal B, Barsegyan A, Lee S. Roozendaal B, et al. Prog Brain Res. 2008;167:79-97. doi: 10.1016/S0079-6123(07)67006-X. Prog Brain Res. 2008. PMID: 18037008 Review.
Pelletier JG, Paré D. Pelletier JG, et al. Biol Psychiatry. 2004 Mar 15;55(6):559-62. doi: 10.1016/j.biopsych.2003.08.019. Biol Psychiatry. 2004. PMID: 15013823 Review.
Atsak P, Roozendaal B, Campolongo P. Atsak P, et al. Neuroscience. 2012 Mar 1;204:104-16. doi: 10.1016/j.neuroscience.2011.08.047. Epub 2011 Aug 27. Neuroscience. 2012. PMID: 21893167 Review.
de Quervain DJ, Aerni A, Schelling G, Roozendaal B. de Quervain DJ, et al. Front Neuroendocrinol. 2009 Aug;30(3):358-70. doi: 10.1016/j.yfrne.2009.03.002. Epub 2009 Mar 31. Front Neuroendocrinol. 2009. PMID: 19341764 Review.
Ferry B, McGaugh JL. Ferry B, et al. Acta Pharmacol Sin. 2000 Jun;21(6):481-93. Acta Pharmacol Sin. 2000. PMID: 11360681 Review.
Aukema RJ, Petrie GN, Matarasso AK, Baglot SL, Molina LA, Füzesi T, Kadhim S, Nastase AS, Rodriguez Reyes I, Bains JS, Morena M, Bruchas MR, Hill MN. Aukema RJ, et al. Neuropsychopharmacology. 2024 Aug 9. doi: 10.1038/s41386-024-01927-x. Online ahead of print. Neuropsychopharmacology. 2024. PMID: 39117904
Han Y; COVID-Dynamic Team; Adolphs R. Han Y, et al. iScience. 2024 Jun 24;27(7):110378. doi: 10.1016/j.isci.2024.110378. eCollection 2024 Jul 19. iScience. 2024. PMID: 39100924 Free PMC article.
Malagón G, Marigold DS. Malagón G, et al. Exp Brain Res. 2024 Jul;242(7):1697-1708. doi: 10.1007/s00221-024-06850-7. Epub 2024 May 28. Exp Brain Res. 2024. PMID: 38806711
Kooiker CL, Birnie MT, Floriou-Servou A, Ding Q, Thiagarajan N, Hardy M, Baram TZ. Kooiker CL, et al. bioRxiv [Preprint]. 2024 Apr 29:2024.04.28.591547. doi: 10.1101/2024.04.28.591547. bioRxiv. 2024. PMID: 38746198 Free PMC article. Preprint.
Becker N, Kühn S, Olsson A. Becker N, et al. Learn Mem. 2024 May 13;31(4):a053891. doi: 10.1101/lm.053891.123. Print 2024 Apr. Learn Mem. 2024. PMID: 38740426